[1] Xia H, Zhang H, Xin X, et al. Surgical management of recurrence of primary intrahepatic bile duct stones. Can J Gastroenterol Hepatol, 2023, 2023:5158580. [2] Takimoto A, Fumino S, Iguchi M, et al. Current treatment strategies for postoperative intrahepatic bile duct stones in congenital biliary dilatation: a single center retrospective study. BMC Pediatr, 2022, 22(1):695. [3] Qin J, He Y, Ma L, et al. Efficacy of 3D-printed assisted percutaneous transhepatic one-step biliary fistulation combined with rigid choledochoscopy for intrahepatic bile duct stones. Dig Liver Dis, 2023, 55(12):1699-1704. [4] Li G, Yang Y, Qu Y, et al. Safety and effectiveness analysis of different surgical methods for intrahepatic bile duct stones. Ann Ital Chir, 2024, 95(1):42-48. [5] Jagirdhar GSK, Bains Y, Surani S. Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma. World J Clin Cases, 2024, 12(11):1881-1884. [6] 王浩瑜, 石党辉, 毛宇锋. 肝部分切除联合胆肠吻合术治疗IHBDS患者疗效和其结石残留影响因素分析研究. 实用肝脏病杂志, 2025, 28(4):629-632. [7] Kim TI, Han SY, Lee J, Kim DU. Removal of intrahepatic bile duct stone could reduce the risk of cholangiocarcinoma: A single-center retrospective study in South Korea. World J Clin Cases, 2024, 12(5):913-921. [8] Takimoto A, Fumino S, Iguchi M, et al. Current treatment strategies for postoperative intrahepatic bile duct stones in congenital biliary dilatation: a single center retrospective study. BMC Pediatr, 2022, 22(1):695. [9] Matsubara S, Suda K, Nagoshi S. Endoscopic ultrasound-assisted removal of an intrahepatic bile duct stone. Dig Endosc, 2025, 37(2):204-205. [10] Monino L, Deprez PH, Moreels TG. Percutaneous cholangioscopy with short Spyscope combined with endoscopic retrograde cholangiography incase of difficult intrahepatic bile duct stone. Dig Endosc, 2021, 33(4):e65-e66. [11] 段昌虎, 刘晓晨, 段建峰. 肝部分切除联合胆肠吻合术治疗IHBDS患者疗效比较研究. 实用肝脏病杂志, 2022, 25(1):112-115. [12] 林益坤, 谢朗, 符剑鸣, 等. 肝部分切除联合胆肠吻合术治疗肝内胆管结石患者临床疗效和术后结石复发危险因素分析. 实用肝脏病杂志, 2022, 25(4):591-594. [13] Yu J, He Y, Yao W, et al. Helicobacter pylori CagA promotes the formation of gallstones by increasing the permeability of gallbladder epithelial cells. Helicobacter, 2024, 29(3):e13100. [14] Liu Q, Zheng L, Wang Y, et al. Primary choledocholithiasis occurrence and recurrence is synergetcally modulated by the bile microbiome and metabolome alternations. Life Sci, 2023, 331:122073. [15] Wu Y, Xu CJ, Xu SF. Advances in risk factors for recurrence of common bile duct stones. Int J Med Sci, 2021, 18(4):1067-1074. [16] Sugiura R, Naruse H,Yamato H, et al. Long-term outcomes and risk factors of recurrent biliary obstruction after permanent endoscopic biliary stenting for choledocholithiasis in high-risk patients. J Dig Dis, 2020, 21(4):246-251. [17] Lee YT, Chan FK, Leung WK, et al. Comparison of EUS and ERCP in the investigation with suspected biliary obstruction caused by choledocholithiasis: a randomized study. Gastrointest Endosc, 2008, 67(4):660-668. [18] Obata T, Matsumoto K, Otsuka M. A review of the endoscopic treatment for bile leak followingcholecystectomy and hepatic surgery. Acta Med Okayama, 2025, 79(5):321-328. [19] Ravendran K, Elmoraly A, Thomas CS, et al. Fenestrating versus reconstituting subtotal cholecystectomy: Systematic review and meta-analysis on bile leak, bile duct injury, and outcomes. Cureus, 2024, 16(10):e72769. [20] Futagawa Y, Yasuda J, Shiozaki H, et al. Long-term outcomes of choledochoduodenostomy for choledocholithiasis: increased incidence of postoperative cholangitis after total or distal gastrectomy. Surg Today, 2024, 54(4):331-339. |